A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
NCT03188185
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
278
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
ALKS 5461
DRUG:
ALKS 5461 Placebo
Sponsor
Alkermes, Inc.